Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder". (Q45932085)
Jump to navigation
Jump to search
scientific article published in August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder". |
scientific article published in August 2009 |
Statements
Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder" (English)
Kenji Hashimoto
1 reference
411-2; author reply 412